Did you know we are the only CGT starting materials provider offering both volume-based and cell-count-based RUO Leukopaks? This dual capability offers CGT developers the ability to choose the best option for their specific project needs, timelines, and budgets—without compromising on quality. AllCells® Volume-Based Leukopaks: The standard format for transitioning from RUO to GMP with an average of 15 billion total nucleated cells (TNCs), ideal for maximizing project flexibility. AllCells® Cell-Count-Based Leukopaks: A more budget-friendly option of 10 billion TNCs with enhanced lot-to-lot consistency. Contact us to learn more about these options: https://lnkd.in/gPMUqcWd
AllCells
Biotechnology Research
Alameda, California 8,546 followers
Providing the highest quality, healthy human primary cells for research.
About us
Founded in 1998, AllCells, a Discovery Life Sciences brand, is a market-leading provider of highly characterized primary cell and tissue products, supporting global biomedical organizations seeking to develop and manufacture novel drugs and cell therapies. By providing Clinical Grade and RUO products, custom donor management services, and integrated analytical capabilities, AllCells' comprehensive solutions streamline every stage of development to help bring novel therapies to market faster. Our FDA-registered, IRB-approved, AABB-compliant donor facilities strategically located across the U.S. provide access to healthy, recallable, well-characterized donors with diverse and rare demographics. Our adjacently located processing facilities enable immediate processing, cryopreservation, and a high degree of responsiveness to accommodate custom requests with exceptional quality and deliverability. Backed by over 30 years of combined scientific and regulatory expertise, AllCells is committed to providing flexible and scalable solutions necessary to dynamic, client-specific needs and timelines from inception to commercialization. AllCells – Science at your Service™
- Website
-
https://www.allcells.com/
External link for AllCells
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Alameda, California
- Type
- Privately Held
- Founded
- 1998
- Specialties
- Human Primary Cells, Stem Cells, PBMCs, GMP Allogeneic Clinical Grade Primary Cells, Bone Marrow, Leukopak, Mobilized Leukopak, Cord Blood, and CD34+ Stem cells
Locations
-
Primary
Get directions
1640 S Loop Rd
Suite 250
Alameda, California 94502, US
-
Get directions
1250 Hancock St
Suite 120s
Quincy, Massachusetts 02169, US
-
Get directions
800 Hudson Wy NW Suite 1700
Huntsville, Alabama 35806, US
Employees at AllCells
Updates
-
This Sunday is National Social Media Day! We are excited to continue connecting with our customers using these important platforms.
In recognition of the upcoming National Social Media Day on June 30th, we celebrate the power of social media in connecting people, ideas, and opportunities around the world. Today, we acknowledge the impact of platforms like LinkedIn in fostering professional relationships, sharing knowledge, and driving innovation. We recently reached 20,000 followers on LinkedIn - a testament to our commitment to connecting with all of you. We express our gratitude to our followers, partners, and colleagues around the world for supporting us on this digital journey. Your engagement, insights, and support have played a pivotal role in our success, and we are grateful for this vibrant community that continues to grow around our shared passion for advancing the development of innovative therapies and diagnostics. Let's continue this journey together! Your feedback, collaborations, and contributions are invaluable to us. Stay tuned for more exciting updates and insights from the world of Discovery Life Sciences.
-
-
AllCells® Matched Immune Cell Subsets are cryopreserved and assay-ready, empowering scientists to overcome cell source variability and achieve high-quality, reliable results in CGT, immunotherapy, infectious disease, and vaccine development. Request a quote today and get 20% off with promo code “Match20”. No minimum purchase is required. Take advantage of this special deal today: https://lnkd.in/gkfE9fTw
-
-
We are excited to discuss the latest CGT trends and share more information about our RUO and GMP products during #ISCT24. Find our CGT experts at booth #453! https://lnkd.in/eEHWKS8i Karen Bostwick, Angela Martinovic, Stephanie Burks #celltherapy #genetherapy #cellandgenetherapy
-
-
Are you planning to attend #ISCT24 in Vancouver, May 29-31? We will be exhibiting at booth #453. Connect with our CGT experts Karen Bostwick, Angela Martinovic, and Stephanie Burks to schedule a meeting. We look forward to seeing you! https://lnkd.in/eEHWKS8i #celltherapy #genetherapy #cellandgenetherapy
-
-
Discovery Life Sciences specializes in leukapheresis and custom prospective collections of high-quality CGT starting materials. Our AllCells RUO and GMP products, along with integrated analytical services, have supported complex CGT programs transition seamlessly from early discovery to process development and manufacturing, with an average 98% collection deliverability rate. Connect with us today and let’s shape the future of CGT together! #celltherapy #genetherapy #cellandgenetherapy
-
The recording for our webinar, “Precision Donor Management for Complex CGT Projects,” is now available! AllCells experts engaged in an insightful discussion on how our unique donor management approach achieves the industry-best collection deliverability across a range of real-world complex projects. Watch the on-demand video now: https://lnkd.in/gvh7k5Pp
-
-
Thank you for attending today's LinkedIn Live. Unfortunately, we were unable to resolve the livestreaming issues and will continue to troubleshoot. Please stay tuned on our page for any updates. We will make a recording of the webinar available in the near future.
Join our panel of AllCells experts for a LinkedIn Live event to learn how our donor management approach achieves an average 98% collection deliverability for complex cell and gene therapy (CGT) projects. Gain practical insights from real-world case studies demonstrating how our unique approach can enable success for your programs. The webinar will be streamed on Thursday, April 10 at 3pm Eastern Time (ET). Register today: https://lnkd.in/gTRqecp2
-
-
Join AllCells experts for practical insights and real-world case studies in donor management for a wide range of CGT projects. In this LinkedIn Live, discover how we succeed in donor screening, characterization, and retention, resulting in high collection deliverability. Speakers include Yuki Kato Maves, PhD, Stephanie Burks, Erin Douglas, and Lola Martinez.
Precision Donor Management for Complex CGT Projects
www.linkedin.com
-
Join our panel of AllCells experts for a LinkedIn Live event to learn how our donor management approach achieves an average 98% collection deliverability for complex cell and gene therapy (CGT) projects. Gain practical insights from real-world case studies demonstrating how our unique approach can enable success for your programs. The webinar will be streamed on Thursday, April 10 at 3pm Eastern Time (ET). Register today: https://lnkd.in/gTRqecp2
-